174 filings
Page 3 of 9
8-K
jsceszfjlikobb2fd7j
22 Jan 09
Other Events
12:00am
8-K
a1dtsejo tveb7z29u
20 Jan 09
Other Events
12:00am
8-K
6foj k5s46
2 Jan 09
Entry into a Material Definitive Agreement
12:00am
8-K
jibhde4s5
16 Dec 08
Other Events
12:00am
8-K
ncnav7
31 Oct 08
Inspire Reports Third Quarter 2008 Financial Results
12:00am
8-K
v8z7tbm44hk21to4t
24 Oct 08
Regulation FD Disclosure
12:00am
8-K
wbcb3lnjv733m
16 Oct 08
Other Events
12:00am
8-K
zm9qzygouoniy04 yat3
10 Oct 08
Inspire Initiates Phase 1 Trial of INS117548 for Glaucoma
12:00am
8-K
ledthaynokqbl
30 Sep 08
Other Events
12:00am
8-K
0m5bjc1k2hmla5kl
23 Sep 08
Termination of a Material Definitive Agreement
12:00am
8-K
d0hrb2p ogzo
15 Sep 08
Inspire Announces Plans for Clinical Testing of New Compound
12:00am
8-K
ahl48v10hka
2 Sep 08
Other Events
12:00am
8-K
94n0xm1o
11 Aug 08
Results of Operations and Financial Condition
12:00am
8-K
ifyaotzf6blp1bp0czoj
1 Aug 08
Inspire Provides Update on Cystic Fibrosis Clinical Program
12:00am
8-K
us6f4mspafr
27 Jun 08
Departure of Directors or Principal Officers
12:00am
8-K
sdbe4wzjs w4g2fk
9 Jun 08
Inspire Announces Achievement of Primary Endpoint In Phase 3
12:00am
8-K
hcd8x4prt
8 May 08
Results of Operations and Financial Condition
12:00am
8-K
l99pys2m
25 Apr 08
Inspire to Discontinue Development of Epinastine Nasal Spray
12:00am
8-K
2mb krw33b5djhpyws2p
26 Mar 08
Departure of Directors or Principal Officers
12:00am
8-K
a74u6
10 Mar 08
Departure of Directors or Principal Officers
12:00am